Related Experiment Video

Updated: Jul 14, 2026

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer
28:15

Deficient Pms2, ERCC1, Ku86, CcOI in Field Defects During Progression to Colon Cancer

Published on: July 28, 2010

Expression of cyclooxygenase-2 and its relationship to p53 accumulation in colorectal cancers

Sung-Chul Lim1, Tae-Beum Lee, Cheol-Hee Choi

  • 1Department of Surgery, Chosun University College of Medicine, 375 Seosuk- dong, Dong-gu, Gwangju 501-759, Korea.

Yonsei Medical Journal
|June 28, 2007
PubMed
Abstract

Insights

Cyclooxygenase (COX)-2 expression is linked to colorectal cancer progression but not associated with p53 levels in patients. Further research is needed to understand COX-2 regulation in colorectal cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cyclooxygenase (COX)-2 is an inducible enzyme implicated in colorectal cancer (CRC) development.
  • Wild-type p53 typically suppresses COX-2, suggesting a link between p53 dysfunction and COX-2 overexpression in CRC.
  • Investigating the relationship between COX-2 and p53 is crucial for understanding CRC pathogenesis.

Purpose of the Study:

  • To determine the relationship between COX-2 protein expression and p53 levels in colorectal adenocarcinoma.
  • To analyze the association of COX-2 and p53 expression with clinicopathologic parameters in CRC patients.

Main Methods:

  • Immunohistochemistry was used to assess COX-2 and p53 protein expression in 161 sporadic colorectal adenocarcinoma tissue samples.
  • Clinicopathologic data, including age and tumor invasion depth, were collected and analyzed in relation to protein expression levels.

Main Results:

  • COX-2 expression was observed in 47.8% of colorectal cancers and correlated with tumor invasion depth (p=0.042).
  • p53 positivity was found in 50.3% of cases and associated with patient age (p=0.025) and tumor invasion depth (p=0.014).
  • No significant correlation was found between COX-2 and p53 expression levels (p=0.118).

Conclusions:

  • COX-2 expression may contribute to colorectal cancer progression.
  • The study did not find an association between COX-2 expression and p53 status in the studied CRC cohort.
  • Further investigation is required to elucidate the regulatory mechanisms of COX-2 overexpression in colorectal cancer.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...